CureVac COVID-19 vaccine hits just 48% efficacy in final analysis
German biotech company CureVac announced its COVID-19 vaccine demonstrated 48% efficacy against COVID-19 of any severity in a final readout of late-stage trial data.
via FOX NEWS https://ift.tt/3ycEI6L
No comments:
Post a Comment
Thanks for your comment reply within 24 hours